P2Y12 Platelet Inhibitor [EPC]

96748 reported adverse events

Drugs of this class: TICAGRELOR CANGRELOR CLOPIDOGREL

These side effects are most commonly reported by patients taking drugs of the P2Y12 Platelet Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 7235
1 MYOCARDIAL INFARCTION 4668
2 FATIGUE 4401
3 DIZZINESS 4019
4 DRUG INTERACTION 3502
5 OFF LABEL USE 3370
6 NAUSEA 3346
7 DEATH 3314
8 DRUG INEFFECTIVE 3200
9 DIARRHOEA 3175
See all common reactions for P2Y12 Platelet Inhibitor [EPC]

Drugs of the P2Y12 Platelet Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR STENT THROMBOSIS 1048 0.6072
1 VASCULAR STENT OCCLUSION 180 0.5294
2 VASCULAR STENT STENOSIS 122 0.3861
3 SPINAL EPIDURAL HAEMATOMA 108 0.2323
4 THROMBOSIS IN DEVICE 630 0.2004
5 CORONARY ARTERY RESTENOSIS 114 0.1979
6 RESPIRATORY TRACT HAEMORRHAGE 81 0.1517
7 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1229 0.1507
8 VASCULAR PSEUDOANEURYSM 191 0.1301
9 CORONARY ARTERY DISSECTION 79 0.1167
See all enriched reactions for P2Y12 Platelet Inhibitor [EPC]